Acacia Pharma Ltd., a pharmaceutical company, discovers and develops supportive care drugs. The company focuses on cancer supportive care. Its products include APD405, an injectable formulation of an oral drug for the use of nausea and vomiting; APD209, which is for the use of cancer cachexia; and APD421, an intravenous formulation for the use of prevention and treatment of nausea and vomiting. The company also concentrates its discovery efforts in cancer related fatigue, cancer cachexia, and xerostomia. Acacia Pharma Ltd. was incorporated in 2006 and is based in Cambridge, United Kingdom.

Sunovion Pharmaceuticals Inc. (formerly Sepracor) engages in discovering, developing, and commercializing therapeutic products for patients suffering from central nervous system disorders, respiratory disorders, and other illnesses. Its products include LUNESTA medicine that helps people sleep better; XOPENEX levalbuterol HCl inhalation solution; and BROVANA aformoterol tartrate inhalation solution. The company's products also comprise OMNARIS ciclesonide nasal spray; ALVESCO ciclesonide HFA inhalation aerosol; and LATUDA, an oral antipsychotic tablet for the treatment of schizophrenia. It offers products for the treatment of depression, epilepsy, neuropathic pain, and insomnia, as well as respiratory conditions, such as asthma, allergic rhinitis, and chronic obstructive pulmonary diseases.

LB Pharmaceuticals is a development stage life sciences company devoted to commercializing novel and improved versions of successful CNS treatments used extensively overseas but never developed, approved, or marketed in the United States. Its approach is to create a research-focused organization dedicated to generating novel intellectual property around improved versions of these former best-selling drugs

Manufactures pharmaceuticals for cardiovascular treatment, central nervous system, internal medicine drugs and oncology treatment

Venturepharma, Inc. manufactures pharmaceutical products. It offers VP discovery, API development and outsourcing, biopharmaceuticals discovery, RX and OTC. The firm provides products for oncology, CNS, dermnova, diabetes, cardiovascular, respiration and vaccine. The company was founded in 1998 and is headquartered in Haidian, China.

Lupin Ltd. is an innovation led transnational pharmaceutical company, which engages in the manufacture of pharmaceutical products. It offers branded and generic formulations, biotechnology products, and active pharmaceutical ingredients. The firm caters to the cardiovascular, diabetology, asthama, pediatrics, central nervous system, gastro-intestinal, anti-infectives, nonsteroidal anti-inflammatory drug therapy, anti-tuberculosis, and cephalosporins industry segments. It operates through the following geographical segments: India, USA, Japan, and Others. The company was founded by Desh Bandhu Gupta in 1968 and is headquartered in Mumbai, India.

BioMed Valley Discoveries, Inc. is a private company headquartered in Kansas City, MO, that operates as a biotechnology company which develops therapies for cancer, inflammation and infectious disease. It was founded by Saurabh Saha.\nThe company says this about itself: BioMed Valley Discoveries is a clinical stage biotechnology company focused on addressing unmet medical needs in a variety of therapeutic and diagnostic areas. In addition to the ERK inhibitor, BVD's portfolio includes an oncolytic bacteria that has completed enrollment for a Phase I study, a selective phosphoinositide 3-kinase gamma inhibitor in late preclinical testing, and two early-stage antibodies targeting the tumor microenvironment.

Synthelabo was a pharmaceutical company which was focused on cardiovascular disease/thrombosis, disorders of central nervous system, oncology and internal medicine. The company was headquartered in Le Plessis-Robinson, France.

Laboratori Baldacci SpA operates as a pharmaceutical company. It offers medicines, supplements and medical devices. The company was founded by Valentino Baldacci in 1904 and is headquartered in Pisa, Italy.

　Jiangsu Alpha Pharmaceutical Co., Ltd. is a cutting-edge field of pharmaceutical intermediates-based pharmaceutical company, is engaged in bulk drugs and pharmaceutical intermediates R & D, manufacturing, trade in one of the new modern high-tech enterprises. The company built in 1976, formerly known as Xinyu chemical plant in Zhangjiagang City, Jiangsu Province in 2007 changed its name to Alpha Pharmaceutical Co., Ltd. 　　The company is located in Suqian City, Jiangsu Province, North Zone Yanshan Road Lakeside Park, is a beautiful environment, garden-like base. As the industry's trusted partner, Alpha Pharmaceutical quality products and services to help customers achieve greater success. Develops new technologies and uses open up additional market opportunities. It combines economic success with environmental protection and social responsibility concept, contributing to a better future. 　　The company is mainly engaged in Atorvastatin, Rosuvastatin, Pitavastatin statins and other series products, is currently the size of the leading and professional manufacturers, with a large number of world-renowned pharmaceutical companies to establish long-term friendly relations of cooperation. 　　The company has always been to technological innovation for the development of the concept, the establishment of Jiangsu Province chiral drugs Engineering Technology Center, Southeast University - Alpha and other lipid-lowering drugs Joint Laboratory Technology Center, will focus on long-term technology leadership in this area, the company will continue to uphold the "Care human health, people-oriented "business philosophy, the development of independent innovation system, the development of more reliable and efficient products. Always concerned about the development of the health industry, the quality of their products to the customers around the world.

Zhejiang Huahai Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products. It also integrates and intermediates formulations such as Active Pharmaceutical Ingredients. Its products include Irbesartan and Hydrochlorothiazide Tablet, Paroxetine Hydrochloride Tablet and Irbesartan Tablet. The company was founded in 1989 and is headquartered in Zhejiang, China.

Hebei Longhai Pharmaceutical Co., Ltd., established on 1998-07-27, The scope of business includes the manufacture of chemical preparations.(Excluding pre-approval and government prohibition,Restrictions);hard capsule,soft capsule,tablet,Granules,pill(water pill),injection(National Prohibition,Except for restricted items)Production,Sales;medicine,Pharmaceutical Intermediates,Daily Chemicals,Research and development of health food,Production,Sales(Raw materials for all the above items,Class I drugs,Precursors,chemical hazards,National Prohibition,Except for restricted items),technology transfer,technical consulting,Technical Services;Medical Information Consulting Service;own house,mechanical equipment,office furniture,Household appliance rental;Agricultural product acquisition.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Torrent Pharma, with annual revenues of more than Rs 8,000 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 20,500 crores. It is ranked 8th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (CV), Central Nervous System (CNS), Gastro-intestinal (GI), and Vitamins Minerals Nutritionals (VMN). Torrent has 8 manufacturing facilities (7 in India & 1 in US), of which 5 are USFDA approved. With R&D as the backbone for its growth in domestic & overseas market, it has invested significantly in R&D capabilities with state-of-the-art R&D infrastructure employing around 700 scientists. The acquisition of Elder Pharma's Indian branded business in 2013, Dermaceuticals business of Zyg Pharma in 2015, API plant of Glochem Industries in 2016, Women healthcare brands from Novartis and Unichem's Indian branded business along with its Sikkim Plant in 2017 strengthened Torrent Pharma's position in the Indian Pharma market. Torrent Pharma started international acquisitions in 2005 with the 90 year old Heumann from Pfizer to enter the German market. In January 2018, Torrent also acquired Bio-Pharm, Inc. (BPI) a generic pharmaceuticals and OTC Company, based in Levittown Pennsylvania, USA, which also included a US FDA registered manufacturing facility. Today, the Company has presence in more than 40 countries and is ranked No. 1 among the Indian pharma Companies in Brazil, Germany, and the Philippines.

Guangdong Jincheng Jinsu Pharmaceutical Co., Ltd., established on 2015-05-25, Business scope includes pharmaceutical production;Pharmaceutical business;Medical Technology Development,consult.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Guangan Kite Pharmaceutical Co., Ltd., established on 2007-09-27, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production;Drug import and export;Drug Wholesale;Drug retail;Import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Chemical product sales(No licensed chemical products);Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Shandong Anhong Pharmaceutical Co., Ltd., established on 2009-06-01, Business scope includes pharmaceutical production;Drug Wholesale;Drug import and export;Drug Manufacturing;road freight transport.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Zezheng (Jinan) Biotechnology Co., Ltd., established on 2019-07-08, Business scope includes biotechnology extension services;Manufacturing of chemical preparations(Free of Hazardous Chemicals);Manufacturing of chemical raw materials(Free of Hazardous Chemicals);Biopharmaceutical Manufacturing(Free of Hazardous Chemicals);Sanitary materials and medical supplies manufacturing;Pharmaceutical special equipment manufacturing;Medical Research and Experimental Development;wholesale,retail:Medical Supplies and Equipment,cosmetic,hygiene products,Health food and others by law,regulations,Items that are not prohibited by the State Council's decision and do not require a business license.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

GW Pharma Ltd., a subsidiary of Jazz Pharmaceuticals Plc, is a company headquartered in Histon, UK, that manufactures pharmaceutical products. It was founded in 1999.